The Analyst Who Loved Bank Stocks for 15 Years Just Flipped. Here's What He's Buying Instead

Oppenheimer’s Chris Kotowski cut Goldman Sachs to Underperform from Perform and downgraded Morgan Stanley, Bank of America, and Citigroup in a June 30, 2026 note, arguing banks are priced for perfection: investment banks trade ~107% relative P/E vs a historical 70–75% range (commercial banks ~78%). He cited performance that looks “priced in” (e.g., Goldman Q1 2026 EPS of $17.55 and investment banking fees up 48% to $2.84B; Citi Markets revenue crossing $7B) while pointing to rate-risk to NII (BofA warns a 100 bps rate decline could cut net interest income by ~$2B) and capital pressure (Goldman CET1 down to 12.5% from 14.3%). Kotowski rotated toward fee/perpetual-capital alternatives like Blackstone and KKR, highlighting BX Q1 2026 AUM of $1.3T (+12% YoY), $68.5B quarterly inflows, fee-related earnings up 23% to $1.55B, and KKR Q1 adjusted EPS of $1.39 (+10.28% beat) alongside stronger forward multiples vs banks.

Analysis

This is less a macro call than a valuation regime shift: the market has been paying banks for peak-cycle earnings quality while underpaying fee-based compounds with longer-duration cash flows. That creates an attractive relative-value setup, but the best expression is not outright short financials; it is long BX/KKR versus GS/MS, where the multiple gap can re-rate quickly if capital markets activity stays merely decent and fundraising momentum holds. Commercial banks like USB/PNC are the cleaner hedge inside the group because they lack the same franchise-duration premium that is now vulnerable to compression.

The key second-order effect is that falling rates are not automatically bullish for banks if deposit betas and securities accretion stay stubbornly favorable from prior vintages. That means the market may be overpricing a curve-driven NII rebound while underestimating how much current profitability is already embedded in share prices. For the alt managers, the near-term risk is that private-credit and fundraising scrutiny turns into a flow slowdown; however, their perpetual-capital mix and wealth-channel distribution should cushion earnings better than consensus expects over the next 2-3 quarters.

Contrarian view: the move may be overstated on the bank short side because the strongest balance sheets can still compound through buybacks and capital return if spreads remain stable. The cleaner downside catalyst for BX/KKR/Ares is not valuation, but a two-step process: slower inflows first, then lower realization fees and performance revenue later. Falsifiers are straightforward: if GS/MS earnings re-accelerate without sacrificing CET1, or if BX/KKR report a visible slowdown in fundraising/fee-related earnings, the rotation trade should be cut.

Key Decisions for Investors

• Enter a 3-6 month pair: long BX / short GS, sized 1:1 beta-adjusted. Thesis is multiple re-rating from fee-based durability versus bank earnings that are already close to peak; target 10-15% relative outperformance, stop if GS holds its multiple after the next two earnings prints.
• Prefer long KKR over MS on any post-earnings weakness. KKR has more visible wealth/AUM compounding and less dependence on underwriting cycle than MS; risk/reward improves if KKR trades back to a forward P/E discount to BX narrowing from current levels.
• Use USB or PNC as the bank-side hedge instead of BAC/C if you want lower event risk. They are less exposed to the 'banks are cheap' narrative unwind and should hold up better if the sector de-risks without a sharp rate shock.
• Avoid initiating fresh outright shorts in GS/MS unless bank earnings confirm a guide-down in buybacks or trading revenue. Near term, the better entry is after any post-earnings pop fades; valuation-only shorts can squeeze quickly.
• Alert item: if BX/KKR fundraising or fee-related earnings decelerate for one quarter, cover the long leg immediately. That would falsify the 'perpetual capital beats cyclical intermediaries' thesis and likely unwind the rotation trade.